QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 sonnet-biotherapeutics-collaborates-with-spanios-on-non-clinical-study-using-nam-based-pdt-platforms-that-emulate-tme-ex-vivo-to-evaluate-effect-of-son-1010-in-soft-tissue-sarcoma

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study using New Alternate M...

 sonnet-biotherapeutics-q3-eps-095-misses-049-estimate

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate...

 sonnet-biotherapeutics-announces-expansion-of-its-phase-1b2a-clinical-study-evaluating-the-combination-of-son-1010-with-genentechs-atezolizumab-in-patients-with-platinum-resistant-ovarian-cancer

Sonnet's lead product, SON-1010 (IL12-FHAB), is being evaluated in combination with atezolizumab (Tecentriq®) in patients w...

 palantir-the-trade-desk-tilray-sonnet-biotherapeutics-and-tesla-why-these-5-stocks-are-on-investors-radars-today

U.S. stocks traded mostly flat on Monday as investors reacted to President Donald Trump's announcement of a 30% tariff on a...

 why-is-sonnet-biotherapeutics-stock-trading-higher-on-monday

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain tokens.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION